MedTrace Logo

Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema

NCT04332133 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-04-03

No results posted yet for this study

Summary

The aim of this study is To compare the anatomical and functional results of intravitreal( IV) injection of ranibizumab with sub threshold micropulse laser ( SML) in treatment of Diabetic macular edema (DME) both anatomically by spectral domain optical coherence tomography (SD OCT) and functionally by best-corrected visual acuity (BCVA) and multifocal electroretinogram (mfERG).

Conditions

Interventions

PROCEDURE

laser interference,INTRAVITREAL INJECTION

sub threshold micro pulse laser for DME for group 1 and intravitreal injection of Ranibizumab for group 2

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Raafat Abdallah, A.professor · ophthalmology department,faculty of medicine, minia university

  • Mahmoud Genidy, professor · ophthalmology department,faculty of medicine, minia university

  • Wagiha Massoud, professor · ophthalmology department,faculty of medicine, minia university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-03-31
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04332133 on ClinicalTrials.gov